SAB Biotherapeutics, Inc. - Warrant

Share · US78397T1117 · SABSW (XNAS)

Overview

Analyst Grade Summary

Buy

Strong Buy

Buy

Hold

Sell

Strong Sell

No Price

03.11.2025 16:09

Current Prices from SAB Biotherapeutics, Inc. - Warrant

Exchange	Ticker	Currency	Last Trade	Price	Daily Change
NASDAQ	SABSW	USD	03.11.2025 16:09	0,03 USD	-0,0006 USD -1,70 %

Share Float & Liquidity

Free Float 82,86 %

Shares Float 8,62 M

Shares Outstanding 10,41 M

Company Profile for SAB Biotherapeutics, Inc. - Warrant Share

SAB Biotherapeutics, Inc., a biopharmaceutical company, develops immunotherapies against infectious diseases, autoimmune diseases, and oncology. It offers SAB-142 anti-thymocyte globulin for Type 1 diabetes; SAB-176 for seasonal influenza; and SAB-301 for Middle East Respiratory Syndrome Coronavirus (MERS-COV). SAB Biotherapeutics, Inc. was incorporated in 2014 and is based in Sioux Falls, South Dakota with an additional office in Cambridge, Massachusetts.

Get up to date insights from finAgent about SAB Biotherapeutics, Inc. - Warrant

Company Data

Name SAB Biotherapeutics, Inc. - Warrant

Company SAB Biotherapeutics, Inc.

Symbol SABSW

Website http://www.sabbiotherapeutics.com

Primary Exchange

NASDAQ

ISIN US78397T1117

Asset Class Share

Sector Healthcare

Industry Biotechnology

CEO Samuel J. Reich

Country United States of America

Currency USD

Employees 0,1 T

Address 2100 East 54th Street North, 33140 Sioux Falls

IPO Date 2021-10-25

ID Changes

Date	From	To
25.10.2021	BCYPW	SABSW

Ticker Symbols

Name	Symbol
NASDAQ	SABSW

More Shares

Investors who hold SAB Biotherapeutics, Inc. - Warrant also have the following shares in their portfolio:

DZ BANK IS.A2943 Bond

SABIC CAP. I 20/50 Bond

The financial platform MoneyPeak tracks and analyzes investments and portfolios. From securities portfolios to crypto purchases.
Useful, simple, and free. Stocks, ETFs, ETCs, ETNs, indices, funds, bonds, certificates, currencies, options, rights issue.

Imprint Data Protection Blog Community Feedback Changelog